Anti-TRIM13 monoclonal antibody

Pre-made anti-TRIM13 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TRIM13/TRIM13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2176-Ab-1/ GM-Tg-hg-IP2176-Ab-2Anti-Human TRIM13 monoclonal antibodyHuman
GM-Tg-rg-IP2176-Ab-1/ GM-Tg-rg-IP2176-Ab-2Anti-Rat TRIM13 monoclonal antibodyRat
GM-Tg-mg-IP2176-Ab-1/ GM-Tg-mg-IP2176-Ab-2Anti-Mouse TRIM13 monoclonal antibodyMouse
GM-Tg-cynog-IP2176-Ab-1/ GM-Tg-cynog-IP2176-Ab-2Anti-Cynomolgus/ Rhesus macaque TRIM13 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2176-Ab-1/ GM-Tg-felg-IP2176-Ab-2Anti-Feline TRIM13 monoclonal antibodyFeline
GM-Tg-cang-IP2176-Ab-1/ GM-Tg-cang-IP2176-Ab-2Anti-Canine TRIM13 monoclonal antibodyCanine
GM-Tg-bovg-IP2176-Ab-1/ GM-Tg-bovg-IP2176-Ab-2Anti-Bovine TRIM13 monoclonal antibodyBovine
GM-Tg-equg-IP2176-Ab-1/ GM-Tg-equg-IP2176-Ab-2Anti-Equine TRIM13 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2176-Ab-1/ GM-Tg-hg-IP2176-Ab-2; GM-Tg-rg-IP2176-Ab-1/ GM-Tg-rg-IP2176-Ab-2;
GM-Tg-mg-IP2176-Ab-1/ GM-Tg-mg-IP2176-Ab-2; GM-Tg-cynog-IP2176-Ab-1/ GM-Tg-cynog-IP2176-Ab-2;
GM-Tg-felg-IP2176-Ab-1/ GM-Tg-felg-IP2176-Ab-2; GM-Tg-cang-IP2176-Ab-1/ GM-Tg-cang-IP2176-Ab-2;
GM-Tg-bovg-IP2176-Ab-1/ GM-Tg-bovg-IP2176-Ab-2; GM-Tg-equg-IP2176-Ab-1/ GM-Tg-equg-IP2176-Ab-2
Products NameAnti-TRIM13 monoclonal antibody
Formatmab
Target NameTRIM13
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TRIM13 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2176-Ag-1Recombinant multi-species TRI13/ TRIM13/ CAR protein
    ORF Viral VectorpGMLPm002628mouse Trim13 Lentivirus plasmid
    ORF Viral VectorvGMLPm002628mouse Trim13 Lentivirus particle


    Target information

    Target IDGM-IP2176
    Target NameTRIM13
    Gene ID10206,66597,364398,707239,607845,101093233,535190,100055194
    Gene Symbol and Synonyms3110001L12Rik,CAR,DLEU5,LEU5,RFP2,RNF77,TRIM13
    Uniprot AccessionO60858,Q5M7V1,Q32L60
    Uniprot Entry NameTRI13_HUMAN,TRI13_RAT,TRI13_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000204977
    Target ClassificationTumor-associated antigen (TAA)

    The target: TRIM13, gene name: TRIM13, also named as CAR, DLEU5, LEU5, RFP2, RNF77. This gene encodes a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This gene is located on chromosome 13 within the minimal deletion region for B-cell chronic lymphocytic leukemia. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.